Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Both are currently Food and Drug Administration (FDA) approved for adults with different indications for use
Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence
they can help pick the best option based on what a patient needs
No lethal dose has been identified
Slowing gastric emptying and reducing appetite Decreasing postprandial and fasting glucose, as well as serum triglycerides Pharmacokinetics Synthetic GLP-1 agonists are resistant to degradation by DPP-4 , giving them a longer half-life than endogenous GLP-1
US$ 28.55
US$ 28.93
US$ 28.49
US$ 26.77
